China Life Insurance plans to invest 2.8 billion yuan, with Lu Zhenghua succeeding in establishing the Xinrui Sci-Tech Innovation Relay Fund, focusing on the private equity secondary market.

MaticHoleFiller · 2026-03-25T10:06:23+00:00

China Life Insurance Company announced its plan to invest 2.8 billion yuan to jointly establish a partnership with relevant parties, focusing on the private equity secondary market and supporting the field of technological innovation. The project is expected to complete the signing of the partnership agreement by December 31, 2026, which will help improve the quality and returns of equity investments.

MaticHoleFiller

2026-03-25 10:06:23

Abstract generation in progress

Guanjian.com News: On March 25, China Life Insurance Co., Ltd. announced its related-party transaction involving the establishment of a partnership.

According to the announcement, China Life plans to invest 2.8 billion RMB to jointly establish a partnership with related parties, with a total committed capital of 4.0154 billion RMB.

This fund focuses on the secondary private equity market, investing in technology innovation sectors supported by national policies through secondary fund shares and continuation restructuring funds, covering industries such as new-generation information technology, biomedicine, high-end manufacturing, new materials, new energy, and energy conservation and environmental protection.

Participants in this transaction include limited partners China Life, Fujian Provincial Government Investment Fund Co., Ltd., and Fuzhou Jintou Industrial Investment Co., Ltd.; general partner Guangzhou Jinhong Zhiyuan Industrial Investment Co., Ltd.; special limited partner Fuzhou Herui Industrial Investment Partnership; and the manager Guoshou Jinshi Asset Management Co., Ltd.

The announcement disclosed that on March 25, 2026, during the 25th meeting of the eighth board of directors, China Life’s board approved the proposal with 7 votes in favor, 0 against, and 0 abstentions, with related directors abstaining from voting. This transaction is a related-party transaction but does not constitute a major asset reorganization, does not meet the standards for shareholder approval, and does not require approval from relevant authorities. The partnership agreement and related agreements are expected to be signed before December 31, 2026.

China Life stated that this transaction will help the company seize the rapid development opportunities in the secondary private equity market, improve the quality and returns of its equity investment portfolio, and promote the construction of China Life’s technology ecosystem. Fujian Province has a developed private economy, a solid industrial foundation, and an active private equity investment ecosystem, which is conducive to the smooth implementation and subsequent operation of the partnership’s investments.

Disclaimer: The content and data of this article are compiled by Guanjian.com based on publicly available information and do not constitute investment advice. Please verify before use.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.